Table 3 Correlation of baseline gut diversity (Inverse Shannon Diversity) with phenotype of tumor-infiltrating lymphocytes during chemoradiation treatment.

From: Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation

 

P value*

Q value

R2

CD4+ Ki.67+ at T4

0.004‡

0.0714

—

CD4+ CD69+ at T3

0.004‡

0.1429

—

CD4+ PD1+ at T3

0.0367‡

0.2143

—

CD4+ CTLA4+ at T3

0.057

0.2857

—

CD4+

—

—

0.1

  1. The percent of live lymphocytes expressing each marker was correlated with baseline Shannon diversity of the gut microbiome.
  2. *P value correlation of immune metric with baseline gut diversity.
  3. ‡Significant P value <0.05.
Back to article page